Search
Electrophysiology and Arrhythmia Program
The UCSF Cardiac Electrophysiology and Arrhythmia Service is known worldwide for expert evaluation and treatment of patients with a variety of heart rhythm disorders.Renowned Pulmonary Disease Specialist to Lead UCSF Pulmonology Program
Prescott Woodruff, MD, MPH, a renowned leader in the pathogenesis and treatment of airway disease, has been appointed chief of UC San Francisco’s Division of Pulmonary, Critical Care, Allergy and Sleep Medicine. Prescott will assume the role of chief on July 1.Novel Hyperglycemia Management Protocol for Patients Undergoing Cancer Treatment
An innovative hyperglycemia management protocol for patients receiving cancer therapy is provided through an urgent-care site within the UCSF Infusion Center, and can be replicated at other centers. The protocol ensures that patients promptly get the necessary treatment for acute hyperglycemia that can occur during cancer therapy.Seizures Stopped, Speech Preserved After Rare Auditory Cortex Tumor is Removed: A UCSF Case Study
The extraordinary success was made possible through research on the neural mechanisms of speech by Edward Chang, MD, UCSF neurosurgeon and chair of the Department of Neurological Surgery, and an advanced phase 2 surgical evaluation by the UCSF Epilepsy Center team.Renowned Expert to Lead UCSF’s Hematology and Oncology Division
Krishna Komanduri, MD, an international leader in hematology-oncology, transplantation and cellular immunotherapy, is the new chief of UCSF’s Division of Hematology and Oncology.UCSF Prostate Cancer Specialist Inducted into Annual Class of “Giants of Cancer Care”
Eric Small, MD, has been announced as one of the winners of the 10th annual Giants of Cancer Care® awards.New Research on Cell Regeneration Shows Promise for Treating Lung Injury and Fibrosis
In a new study, UCSF researchers showed that they could successfully redirect profibrotic murine lung cells to a nonfibrotic state in which they regenerated alveoli. These findings could lead to novel treatments for lung injury and fibrosis.New Tinnitus Research Focused on Neural Networks Shows Promise for Precision Treatment
Using advanced neuroimaging, UCSF researchers are exploring the root causes of tinnitus and developing novel treatments for this potentially debilitating condition, which affects more than 50 million Americans.Genetic Gut Microbiome Variations Point to Precision Treatments for Metabolic Conditions
In a new study, UCSF researchers found that the gut microbiome of East Asians is distinct from that of White individuals living in the same geographic region. This discovery may lead to personalized treatments for various metabolic conditions, including diabetes and obesity.UCSF Lung Transplant Patient No. 1,000 Looks Ahead to More of the Good Life
Hospital Innovations Boost 3-Year Survival From 50% in 2001 to 90% 20 Years LaterAdvancing Precision Medicine for Neuro-Oncology Patients: Q&A with David Solomon, MD, PhD
UC San Francisco neuropathologist and molecular neuro-oncologist David Solomon, MD, PhD has reached a unique and impressive milestone: the publication of his team's 50th neuro-oncology research study stemming from the UCSF500 Cancer Gene Panel, a molecular diagnostic test that identifies genetic changes in the DNA of a patient's cancer.Best Practices for Implementing Virtual and Hybrid Cardiac Rehabilitation Programs
In a new study, UCSF researchers found that patients participating in either virtual or hybrid cardiac rehabilitation (CR) programs showed similar improvements in functional capacity to those of in-person CR program participants. Hybrid programs combine in-person and virtual delivery.Precision Prostate Cancer Treatment Reduces ADT-Related Dementia Risk
In a new study, UCSF researchers found that cumulative androgen deprivation therapy (ADT) exposure was associated with the onset of dementia in a nationwide longitudinal registry of men with prostate cancer.Virtual Cardiac Rehabilitation Produces Similar Results as In-Person Treatment
UCSF Study Shows Potential Benefit of Expanding Availability for Patients Cardiac rehabilitation (CR) reduces hospitalization and mortality and improves quality of life for patients with cardiovascular disease. Despite its benefits, only 24 percent of eligible patients in the U.S. participate in CR due to financial and logistical barriers.Endoscopic Removal of Benign Complex Colorectal Lesions Improves Patient Outcomes
Endoscopic mucosal resection (EMR) is a safe and effective alternative to surgery for benign complex colorectal lesions, according to research led by UCSF gastroenterologist Tonya Kaltenbach, MD.Regenerative Medicine Could Soon Transform Treatment of Musculoskeletal Conditions
UCSF’s Brian Feeley, MD, and Xuhui Liu, MD, in collaboration with Kevin Healy, PhD, received a $1.2 million grant for their lab from the California Institute of Regenerative Medicine to continue pursuing their translational research in regenerative medicine.Custom Cochlear Implant Programming Shows Promise for Improving Music Perception
A new clinical trial underway at UCSF, High-Resolution CT-Guided Cochlear Implant Programming, aims to improve speech and music perception for cochlear implant (CI) users.3D Facial Analysis Shows Biologic Basis for Gender-Affirming Surgery
In order to validate surgical decisions for gender-affirming facial surgery, researchers from the UC San Francisco and the University of Calgary set out to quantify the effect of sex on adult facial size and shape through an analysis of three-dimensional (3D) facial surface images.New Laryngopharyngeal Sensitivity Test Could Transform Patient Care
UCSF researchers have developed a first-of-its-kind technique to objectively evaluate laryngopharyngeal sensation.Novel Technique Improves Skin Color Match in Facial Reconstruction
A new procedure developed by UCSF facial plastic surgeons provides patients undergoing microvascular facial reconstruction with a more accurate skin color match than was previously possible.UCSF Deploys Innovative Data System to Integrate Research and Care
UC San Francisco (UCSF), in collaboration with the Quantum Leap Healthcare Collaborative (QLHC) and the U.S. Food and Drug Administration (FDA) has developed the OneSource system to seamlessly integrate clinical care and research data.UCSF’s Dr. Mitchel Berger on the Cancer Moonshot Relaunch
On Feb. 2, 2022, Mitchel Berger, MD, neurosurgeon and director of the UCSF Brain Tumor Center, attended the relaunch of the White House’s Cancer Moonshot initiative at the invitation of President Joe Biden and Dr. Jill Biden.UCSF Neurologist to Receive Prestigious Scientific Award
Stephen L. Hauser, MD, Professor of Neurology and Director of the UCSF Weill Institute for Neurosciences, has been chosen by the American Brain Foundation (ABF) to receive its second annual Scientific Breakthrough Award. Hauser is being honored for his career-long commitment to advancing the understanding of the genetic basis, immune mechanisms and treatment of multiple sclerosis (MS).How to Assign Malignancy Risk to Adnexal Masses Based on Imaging Features
Adoption of the Ovarian-Adnexal Reporting and Data System (O-RADS) by UCSF radiologists, gynecologists and gynecologic oncologists has reduced ambiguity in ultrasound (US) and MRI reporting of ovarian and adnexal lesions, with enormous potential to improve patient outcomes.